The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MDLN | N/A | N/A | N/A | +5% |
| S&P | +18.89% | +78.8% | +12.32% | +2% |
Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $7.79B | 14.8% |
| Gross Profit | $1.74B | 3.8% |
| Gross Margin | 22.32% | -2.4% |
| Market Cap | $34.08B | 0.0% |
| Market Cap / Employee | $757.32K | 0.0% |
| Employees | 45K | 4.7% |
| Net Income | $180.00M | -37.7% |
| EBITDA | $723.00M | -12.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.94B | 676.8% |
| Accounts Receivable | $3.53B | 0.0% |
| Inventory | 4.8K | 7.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $12.87B | -23.1% |
| Short Term Debt | $143.00M | -7.1% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.11% | 0.0% |
| Return On Invested Capital | 2.15% | 0.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $91.00M | 155.5% |
| Operating Free Cash Flow | $229.00M | 413.7% |
| Metric | Q4 2025 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 29.05 | - | |||
| Price to Book | 2.00 | - | |||
| Price to Sales | 1.20 | - | |||
| Price to Tangible Book Value | -6.26 | - | |||
| Price to Free Cash Flow TTM | 26.98 | - | |||
| Enterprise Value to EBITDA | 74.31 | - | |||
| Free Cash Flow Yield | 3.7% | - | |||
| Return on Equity | 8.5% | - | |||
| Total Debt | $16.90B | $16.65B | $16.65B | $13.01B | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
